NSG
PFE icon

Nalls Sherbakoff Group’s Pfizer PFE Stock Holding History

Nalls Sherbakoff Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4K Sell
1,678
-2,038
-55% -$53.3K 0.03% 204
2026
Q1 		$104K Buy
3,716
+1
+0% +$27 0.08% 138
2025
Q4 		$92.5K Buy
3,715
+2,041
+122% +$51.5K 0.07% 144
2025
Q3 		$42.6K Buy
1,674
+2
+0.1% +$49 0.03% 219
2025
Q2 		$40.5K Buy
1,672
+855
+105% +$19.9K 0.03% 224
2025
Q1 		$20.7K Buy
+817
New +$21.4K 0.02% 245
2023
Q4 		$33.7K Sell
1,172
-50
-4% -$1.51K 0.03% 196
2023
Q3 		$40.5K Sell
1,222
-1
-0.1% -$35 0.04% 169
2023
Q2 		$46.5K Hold
1,223
– – 0.05% 162
2023
Q1 		$49.4K Buy
+1,223
New +$52.8K 0.05% 162
2018
Q4 		$86K Buy
+2,087
New +$86.6K 0.14% 88

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nalls Sherbakoff Group's PFE Position: Q2 2026 in Review

Nalls Sherbakoff Group reduced its Pfizer (PFE) stake by 55% in Q2 2026, selling an estimated $53.3K and leaving 1,678 shares worth $40.4K. The position accounts for 0.03% of the portfolio, ranked #204.

Nalls Sherbakoff Group first reported a position in PFE in Q4 2018 and has held it in 11 quarters since. The position peaked at $104K in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Nalls Sherbakoff Group held 1,678 shares of Pfizer worth $40.4K as of Q2 2026.
  • Nalls Sherbakoff Group sold 2,038 Pfizer shares in Q2 2026, an estimated $53.3K.
  • Pfizer made up 0.03% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #204 holding.
  • Nalls Sherbakoff Group first reported a position in Pfizer in Q4 2018 and has held it in 11 quarters since.
  • Nalls Sherbakoff Group's Pfizer position peaked at $104K in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.